Monkeypox Disease with Predominant Genital Symptoms: A Nigerian Case Report
Archives of Current Research International, Volume 23, Issue 2,
Page 36-42
DOI:
10.9734/acri/2023/v23i2557
Abstract
Mpox presents typically with macular papular body rashes with similar-looking sores in genital or oral areas. It may be missed, or wrongly managed as sexually transmitted infections (STI), especially in settings where symptom-based treatment practices are sufficient for care.
We describe a 40-year-old cisgender male, heterosexual Nigerian who developed some rash in the genital region associated with penile swelling. It was suspected to be syphilis and managed with presumptive antibiotics. Laboratory investigation (PCR) confirmed that it was a Mpox disease, and VDRLT was negative. Notably, in this case, the early symptoms were a paradigm case of Mpox disease presenting as an STI, which syndromically conformed more to an STI than the case definition for a suspected case of Mpox in our setting. Consequently, the expected early containment activities were delayed. This increased the potential of further disease spread. An Update of the standard case definition as well as a reclassification of the disease as a possible STI is recommended for enhanced surveillance, increased case detection, and reduction in the burden of unrecognized cases.
- Mpox
- STI
- case definition
- syphilis
- surveillance
How to Cite
References
World Health Organization. Monkeypox. fact sheet.
Sejvar JJ, Chowdary Y, Schomogyi M, et al. Human monkeypox infection: A family cluster in the Midwestern United States. J Infect Dis. 2004;190:1833–1840.
Kindrachuk J, Arsenault R, Kusalik A, et al. Systems kinomics demonstrates congo basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African Monkeypox Virus. Mol Cell Proteomics. 2012;11:1–12.
World Health Oorganization. Vaccines and immunization for monkeypox; 2022.
Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:734–742.
Grosenbach DW, Honeychurch K, Rose EA, et al. Oral Tecovirimat for the Treatment of Smallpox. N Engl J Med 2018;379:44–53.
Petersen E, Kantele A, Koopmans M, et al. Human Monkey pox Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019;33:1027–1043.
World Health Organization (WHO). Guidelines for the management of symptomatic sexually transmitted infections; 2021.
Federal Ministry of Health. National Guidelines on the Syndromic Management of Sexually Transmitted Infections (STI) and other Reproductive Tract Infections (RTI); 2016.
Rezza G. Emergence of human monkeypox in west Africa. Lancet Infect Dis. 2019;19:797–799.
A brief history of monkeypox in Nigeria.
Ogoina D, James IH. Monkeypox among linked heterosexual casual partners in Bayelsa, Nigeria. Qeios. 2022;2:1–11.
Nigeria Centre For Disease Control (NCDC). Monkeypox Case definitions for Surveillance: Ministry of Health and Family Welfare.
Hammed MR, Elgendy SG, El-Mokhtar MA, Sayed D, Mansour SM DA. T-lymphocytes expression of Toll-like receptors 2 and 4 in acute myeloid leukemia patients with invasive fungal infections. Mediterr J Hematol Infect Dis; 14.
Franklin E, Khan AR. Poxvirus antagonism of innate immunity by Bcl-2 fold proteins. J Struct Biol. 2013;181:1–10.
Sant AJ, McMichael A. Revealing the role of CD4+ T cells in viral immunity. J Exp Med. 2012;209:1391–1395.
Hameed MRA, Nafady HA, Mostafa MI, et al. Possible role of cd11a in primary immune thrombocytopenia patients on immunosuppressive therapy. J Blood Med. 2021;12:197–205.
Saghazadeh A RN. Poxviruses and the immune system: Implications for monkeypox virus. Int Immunopharmacol. 2022;113:109364.
Hammed MR, Yoseryeia A, Ahmed EN, Bakry R EM. sVCAM-1, and TGFβ1 in chronic phase, chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Egypt J Immunol. 2022;29:163–73.
Mohammed D, Khallaf S, El-Naggar M, et al. Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma. Res Oncol. 2021;17: 38–41.
Johnston SC, Johnson JC, Stonier SW, et al. Cytokine modulation correlates with severity of monkeypox disease in humans. J Clin Virol. 2015;63:42–45.
Nigeria Centre For Disease Control (NCDC). Update on Monkeypox in Nigeria; 2022.
Bociąga-Jasik M, Raczyńska A, Lara M, et al. Monkeypox presenting with genital ulcers: A challenging clinical problem. Polish Arch Intern Med. 2022; 132:1–2.
Saks MJ, Grando A, Murcko A, Millea C. Granular patient control of personal health information: Federal and state law considerations. Jurimetrics. 2018;58(4): 411.
-
Abstract View: 57 times
PDF Download: 20 times
